Collate, Inc. Company Profile

Background

Overview

Collate, Inc. is a privately held company headquartered in Menlo Park, California, specializing in AI-powered data intelligence solutions for the life sciences industry. Founded in 2021 by Surbhi Sarna and Nate Smith, Collate focuses on automating documentation processes for diagnostic, medical device, and drug development companies, aiming to accelerate life-saving innovations by creating accurate and efficient documentation.

Mission and Vision

Mission: To accelerate life-saving innovations by creating accurate documentation for the life sciences industry.

Vision: To automate paperwork at every stage of development and commercialization, enabling teams to dedicate more time to their core responsibilities.

Industry Significance

Collate addresses a critical need in the life sciences sector by streamlining the often cumbersome and time-consuming documentation processes, thereby enhancing efficiency and reducing time to market for new medical products.

Key Strategic Focus

Core Objectives

Automate Documentation: Utilize AI to automate the creation and management of regulatory and compliance documents.

Enhance Collaboration: Foster collaboration among data teams through shared definitions, policies, and context.

Ensure Compliance: Maintain high standards of data governance to meet industry regulations.

Areas of Specialization

Regulatory Documentation: Automating the generation of documents required for regulatory submissions.

Clinical Trials: Streamlining documentation processes during preclinical and clinical trial phases.

Product Development: Facilitating documentation needs throughout the product lifecycle.

Key Technologies Utilized

Artificial Intelligence: Employing AI agents to automate documentation and data management tasks.

Semantic Metadata Graphs: Creating unified metadata structures to enhance data understanding and governance.

Open-Source Platforms: Building on OpenMetadata, an open-source standard for metadata management.

Primary Markets Targeted

Diagnostic Companies: Focusing on firms developing diagnostic tools and tests.

Medical Device Manufacturers: Targeting companies involved in the development of medical devices.

Pharmaceutical Firms: Serving drug development companies requiring efficient documentation solutions.

Financials and Funding

Funding History

Total Funds Raised: $10 million.

Recent Funding Round: Series A round completed in July 2025, raising $10 million.

Notable Investors: Venrock, Unusual Ventures, and Karman.

Utilization of Capital

The capital raised is intended to support strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

Pipeline Development

As of the latest available information, specific details regarding Collate's pipeline candidates, stages of clinical trials, target conditions, and anticipated milestones are not publicly disclosed.

Technological Platform and Innovation

Proprietary Technologies

AI Agents: Automating documentation and data management tasks to improve efficiency.

Semantic Metadata Graphs: Establishing unified metadata structures to enhance data understanding and governance.

Significant Scientific Methods

Automated Documentation: Utilizing AI to generate and manage regulatory and compliance documents.

Data Governance: Implementing policies and tools to ensure data quality and compliance.

Leadership Team

Surbhi Sarna: CEO and Founder. Former CEO and Founder of nVision Medical, acquired by Boston Scientific for $275 million. Board member at private and public life sciences companies. Former General Partner at Y Combinator, leading their healthcare practice. Author of "Without a Doubt: How to Go from Underrated to Unbeatable."

Nate Smith: CTO and Founder. Former CEO, CTO, and Founder of Lever, acquired by Employ for $517 million. Former Visiting Partner at Y Combinator and Product Manager at Google.

Competitor Profile

Market Insights and Dynamics

The market for AI-driven data management solutions in the life sciences sector is growing, driven by the increasing complexity of regulatory requirements and the need for efficient data handling.

Competitor Analysis

Alation: Provides an AI and cloud-based platform for enterprise data cataloging.

Collibra: Offers data intelligence solutions via a cloud-based platform.

Atlan: Facilitates data management and governance through an AI-powered platform.

Data.World: Enables data cataloging and collaboration for data scientists.

Strategic Collaborations and Partnerships

Specific details regarding Collate's strategic collaborations and partnerships are not publicly disclosed.

Operational Insights

Collate differentiates itself by focusing on automating documentation processes specifically for the life sciences industry, leveraging AI to enhance efficiency and compliance.

Strategic Opportunities and Future Directions

Collate is well-positioned to expand its offerings by integrating additional AI capabilities, exploring new market segments within the life sciences industry, and forming strategic partnerships to enhance its product suite and market reach.